Beth Geter-Douglass - Concepedia

Author

Beth Geter-Douglass

National Institute on Drug Abuse

Also Known As

B GETER-DOUGLASS, B Geter-Douglass, B. GETER‐DOUGLASS, B. Geter-Douglass, Beth Geter-Douglass

Publications

353

Citations

H-Index

Concepts

All Affiliations

National Institute on Drug Abuse National Institutes of Health

About

Beth Geter-Douglass is an author at National Institute on Drug Abuse specializing in medicine, social sciences, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	182
2	Social Sciences	5	5	161
3	Neuroscience	5	5	161
4	Pharmacology	5	5	116
5	Biochemistry	1	1	21

Beth Geter-Douglass

Publications

333

Citations

H-Index

Page 1

	Year	Citations
NMDA antagonist properties of the putative antiaddictive drug, ibogaine. Piotr Popik, Richard T. Layer, Linda H. Fossom, Journal of Pharmacology and Experimental Therapeutics	1995	99
Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands Jane B. Acri, Sean R. Carter, Ken Alling, European Journal of Pharmacology Substance AbuseNeuropsychologyPsychoactive DrugPsychiatryBehavioral Neuroscience	1995	66
Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice Beth Geter-Douglass, Jeffrey M. Witkin Psychopharmacology NeurophysiologyBehavioral NeuroscienceMedicineBehavioral PharmacologyBehavioural Pharmacology	1999	47
Characterization of Unconditioned Behavioral Effects of Dopamine D3/D2 Receptor Agonists Beth Geter-Douglass, Jonathan L. Katz, Ken Alling, Journal of Pharmacology and Experimental Therapeutics	1997	29
Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice Beth Geter-Douglass, Jeffrey M. Witkin Psychopharmacology Behavioral NeuroscienceMedicineBehavioural PharmacologyPhysiologyFunctional Selectivity	1997	24
Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor. Jeffrey M. Witkin, Sandra R. Brave, Dorothy French, Journal of Pharmacology and Experimental Therapeutics	1995	23
(.+-.)-(Aminoalkyl)benzazepine Analogs: Novel Dopamine D1 Receptor Antagonists Sari Izenwasser, Beth Geter-Douglass, J M Witkin, Journal of Medicinal Chemistry Molecular PharmacologyPsychoactive DrugBiochemistryFunctional SelectivityMedicine	1995	21
Attenuation of the stimulant and convulsant effects of cocaine by 17-substituted-3-hydroxy and 3-alkoxy derivatives of dextromethorphan Agustin Zapata, Maciej Gąsior, Beth Geter-Douglass, Pharmacology Biochemistry and Behavior Molecular PharmacologySubstance Abuse3-Alkoxy DerivativesPsychoactive DrugAddiction	2002	12
Dopamine D1D2 antagonist combinations as antagonists of the discriminative stimulus effects of cocaine Beth Geter-Douglass, Anthony L. Riley Pharmacology Biochemistry and Behavior Substance AbusePsychoactive DrugBehavioral NeuroscienceAddictionMedicine	1996	12

Page 1